Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetaminophen
acetylcholine
acquired immunodeficiency syndrome
acrochordon
acromegaly
advances in neurology
adverse drug reaction
airway obstruction
akathisia
alpha agonists
alpha methyltyrosine
alpha-synuclein
Alzheimer's disease
amenorrhea
ammonia
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, guamian type of
amyotrophic lateral sclerosis, Parkinson-dementia-complex
analgesic
anatomy of
antibiotics
anticholinergic drugs
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
anxiety
anxiolytic agents
apoptosis
aspirin
asterixis
athetosis
attention deficit disorder with hyperactivity
atypical
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
Behcet's syndrome
benzodiazepine
botulinum toxin
bromocriptine
buspirone
butyrophenone
carbon monoxide poisoning
carpal tunnel syndrome
caspases
CAT scan, abnormal
catatonia
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebrovascular accident
children
chlorpromazine
chorea
choreoathetosis
clonazepam
clonidine
clozapine
cluster headache
codeine
compazine
complications
concerta
controversies in neurology
conversion reaction
coprolalia
cost effectiveness
creatine phosphokinase(CPK)elevated
dantrolene sodium
deafness
deanol
deep gray nuclei
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, prevention of
depression
DHE
diabetes mellitus
differential diagnosis
dilantin
dilantin, toxicity
diphenhydramine
domperidone
dopamine
dopamine agonist
dopamine antagonist
dopamine antagonist, peripheral
dopamine depleting agents
dopamine receptor, D2
dopaminergic neurons
droperidol
drug induced neurologic disorders
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dystonia
dystonia, drug induced
dystonia, treatment of
dystonic reaction, acute
emergencies, neurologic
emergency room
encephalitis
encephalitis, Japanese
epidemiology of neurology
ergotamine
erythromelalgia
excitotoxin
extrapyramidal
eye movement, disorders of
Fahr disease
fever
flavivirus
Gilles de la Tourette syndrome
glutamic acid
goiter
growth hormone
guanfacine
hallucination
haloperidol
headache
headache, emergency
headache, evaluation of
headache, prophylaxis
headache, treatment of
hearing loss
hemiballismus
hepatolenticular degeneration(Wilson's disease)
highly active antiretroviral therapy
human immunodeficiency virus type 1
hyperglycemia
hyperhidrosis
hypertension
hyperthermia
hypoglycemia
hyponatremia
hypoxic encephalopathy
iatrogenic neurologic disorders
impotence
impulsivity
iron, brain
Jakob-Creutzfeldt disease
L-dopa
L-dopa, drug interactions with and side effects of
Leigh's disease
leukocytosis
level of consciousness, decreased
Lewy body
Lewy body disease, diffuse
lithium
liver disease
lumbar puncture, indications for
mellaril
meperidine
metoclopramide
migraine
migraine, pregnancy
migraine, prophylaxis
migraine, treatment of
mimics
minocycline
misdiagnosis
motor neuron disease
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, post hemiplegic
movement disorder, treatment of
MRI
MRI, abnormal
MRI, diffusion weighted
MRI, indications for
multiple sclerosis
muscle relaxant
myoclonus
narcotic analgesics
neoplasm, pituitary
neoplasm, pituitary, treatment of
neoplasm, primary of CNS-metastasizing to subarachnoid space
neurochemistry
neuroendocrinology
neurofibromatosis 1
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic testing
neuronal cell death
neuronal degeneration
neurons
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
neurotransmitter
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
obsessive-compulsive disorder
octreotide
oculogyric crisis
olanzapine
osmotic demyelination syndrome
pain
pain, genital
papaverine
paranoia
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, etiology of
Parkinson disease, exacerbation
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism syndrome
Parkinsonism-dementia complex
pathologic gambling
pathology
patient information and support
phenothiazine
physostigmine
pimozide
pituitary
pituitary, adenoma
pituitary, adenoma, giant
pituitary, microadenoma
practice guidelines
pramipexole
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
prolactin, elevated
prolactinoma
promethazine
propranolol
proton beam therapy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
radiation necrosis
radiation therapy, CNS treatment and complications with
recurrent
renal failure
reserpine and reserpine like drugs
reserpine treatment in movement disorder
review article
rigidity
risk factors
sensorineural hearing loss
serotonin agonist
sinemet
single photon emission computed tomography
skin, lesions in neurologic disorders
sleep apnea
smell
sodium-glucoe cotransporter-2 inhibitors
steroid
steroid therapy, CNS treatment and complications with
stimulation, deep brain
sumatriptan
sweating
symmetric brain lesions
synucleinopathy
tardive akathisia
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tardive pain syndrome
tension headache
tetrabenazine
tetracycline
thalamus, lesion of-bilateral
thiothixene
tic
tic, chronic multiple
tic, classification of
tic, motor
tic, recurrent
tic, sensory
tic, vocal
tongue, enlarged
treatment of neurologic disorder
tremor
trifluoperazine
triptans
undiagnosed
Showing articles 350 to 400 of 3868 << Previous Next >>

Cytotoxic Lesions of the Corpus Callosum Caused by Thermogenic Dietary Supplements
AJNR 40:1304-1308, Galnares-Olalde, J.A.,et al, 2019

Pes Cavus and Neuropathy
Neurol 93:e823-e826, Alderson,J.,& Ghosh,P.S., 2019

Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018

Pantothenate Kinase - Associated Neurodegeneration (PKAN)
Emedicine.Medscape Sept, Hanna, P.A. & Benbadis, S.R., 2018

Selenium Toxicity Associated with Reversible Leukoencephalopathy and Cortical Blindness
JAMA Neurol 75:1282-1283, Rae, W.,et al, 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

Preventive Migraine Drug Approved
JAMA 320:1746, , 2018

Hearing and Vision Loss in an Older Man
JAMA Neurol 75:1439-1440, Ho, V.M.,et al, 2018

Surviving Cerebral Malaria
Neurol 91:978-979, Wijdicks, E.F.M. & Park, J.G., 2018

Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018

Implications of the WAKE-UP Trial
Stroke 49:3115-3117, Silver, B. & Arnold, M., 2018

Progressive Gait Difficulty and Incontinence in a 40-year-old Man with HIV
Neurol 91:1065-1070, Silverman, A.,et al, 2018

Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018

Rapid Progression of Reversible Cognitive Impairment in an 80-year-old Man
Neurol 91:1109-1113, Bouthour, W.,et al, 2018

Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018

Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018

Atypical Parkinsonian Syndromes: A General Neurologists Perspective
Eur J Neurol 25:41-58, Deutschlander, A.B.,et al, 2018

Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018

Interventions for Improving Modifiable Risk Factor Control in the Secondary Prevention of Stroke
Stroke 49:e301-e302, Bridgwood, B.,et al, 2018

Mechanical Thrombectomy Outcomes with or without Intravenous Thrombolysis
Stroke 49:2383-2390, Gariel, F.,et al, 2018

Endovascular Stroke Therapy in the Late Time Window
Stroke 49:2559-2561, Schellinger, P.D. & Demaerschalk, B.M., 2018

Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018

Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018

Spinal Cord Infarction Because of Spontaneous Vertebral Artery Dissection
Stroke 49:e314-e317, Montalvo, M.,et al, 2018

White Matter Lesion Related to Decompression Sickness Following Extreme Breath-Hold Diving
Neurol 91:847-848, Guerreiro, C.,et al, 2018

Progressive Multifocal Leukoencephalopathy: Epidemiology, Clinical Manifestations, and Diagnosis
www.UptoDate.com, May, Koralnik, I.J., 2018

Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
NEJM 378:11-22,81, Nogueira, R.G.,et al, 2018

Recurrent Dysarthria and Ataxia in a Young Girl
JAMA Neurol 75:125-126, Romba, M.,et al, 2018

Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy
AJNR 39:24-30, Kinner, S.,et al, 2018

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Mystery Case: A 48-year-old Woman with Bizarre Behavior, Neurologic Symptoms, and Progressive Decline
Neurol 90:242-247, Kesari, N.K.,et al, 2018

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
NEJM 378:708-718, Albers, G.W.,et al, 2018

2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke
Stroke 49:e46-e110, Powers, W.J.,et al, 2018

Subacute Paresis in a 28-year-old man with HIV
Neurol 90:432-435, Harada, Y.,et al, 2018

Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018

Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018

A 52-year-old woman with a 3 weeks of progressive gait ataxia and dysarthria
Neurol 90:e985-e989, Ly, C.,et al, 2018

Fulminant Encephalopathy with Unusual Brain Imaging in Disulfiram Toxicity
Neurol 90:518-519, Peddawad, D.,et al, 2018

A 12-year-old girl with headache and change in mental status
Neurol 90:524-529, Patel, P.,et al, 2018

Primary Thrombectomy in tPA (Tissue-Type Plasminogen Activator) Eligible Stroke Patients with Proximal Intracranial Occlusions
Stroke 49:265-269, Fischer, U.,et al, 2018

Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018

Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018

A 56-year-old woman with acute vertigo and diplopia
Neurol 90:748-752, Sharma, R.,et al, 2018

Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
NEJM 378:1573-1582, Campbell, B.C.V.,et al, 2018

Automated DWI analysis can identify patients within the thrombolysis time window of 4.5 hours
Neurol 90:e1570-e1577, Wouters, A.,et al, 2018

Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018

Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants with Serotonin Syndrome
JAMA Neurol 75:566-572, Orlova, Y.,et al, 2018

A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018



Showing articles 350 to 400 of 3868 << Previous Next >>